Position in CELC
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$53,999,634
+$2,114,886 QoQ
Shares Held
473,100
-9.1% QoQ
Ownership
0.970%
of shares outstanding
% of Portfolio
1.81%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CELC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Nearwater Capital Markets, Ltd holds $319,346,335 across 7 Biotechnology names. CELC ranks #3 (16.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TERN |
Terns Pharmaceuticals, Inc.
|
2,150,400 | $113,369,088 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
678,000 | $65,935,500 | |
| 3 | CELC |
Celcuity Inc.
This page
|
473,100 | $53,999,634 | |
| 4 | INSM |
INSMED Inc
|
300,000 | $49,056,000 | |
| 5 | NKTR |
Nektar Therapeutics
|
261,500 | $18,814,925 | |
| 6 | ARQT |
Arcutis Biotherapeutics, Inc.
|
607,300 | $14,307,988 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,000 | $3,863,200 |
All Filings in CELC
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $53,999,634 | 473,100 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $51,884,748 | 520,200 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||